First-in-Human Study of ICT01 in Patients With Advanced Cancer
NCT04243499
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
292
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor, Adult
Hematopoietic/Lymphoid Cancer
Interventions
BIOLOGICAL:
IV ICT01
Sponsor
ImCheck Therapeutics